Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jan, Buch"'
Autor:
David Collier, Peter S. Sever, Jan Buch, Mark J. Caulfield, Björn Dahlöf, Neil R Poulter, Hans Wedel
Publikováno v:
Journal of Hypertension. 29:592-599
Older patients experience higher rates of cardiovascular disease than younger patients, but may be undertreated with statins due to doubts about efficacy and safety. The Lipid-Lowering Arm of the Anglo-Scandinavian Cardiac Outcomes Trial allowed an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c558ba7a3b743929ddb83c503f0141
https://doi.org/10.1097/hjh.0b013e328342c8f7
https://doi.org/10.1097/hjh.0b013e328342c8f7
Autor:
Neil R Poulter, David Collier, Mark J. Caulfield, Hans Wedel, Björn Dahlöf, Peter S. Sever, Jan Buch
Publikováno v:
Journal of Hypertension. 29:583-591
Older patients experience higher rates of cardiovascular disease than younger patients, but studies have suggested that relative risk reductions due to antihypertensive therapy are lower in older than younger patients. The Anglo-Scandinavian Cardiac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e75d7434359d9bf24c2f3ed488373de
https://doi.org/10.1097/hjh.0b013e328342c845
https://doi.org/10.1097/hjh.0b013e328342c845
Autor:
Jan Buch
Publikováno v:
Advances in Therapy. 27:426-443
Despite the availability of a wide range of effective blood pressure (BP)-lowering agents, a substantial proportion of patients with hypertension fail to achieve target BP levels. The majority of patients with hypertension need a combination of two o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e11abfa671442f3f039379f39d573e25
https://doi.org/10.1007/s12325-010-0039-0
https://doi.org/10.1007/s12325-010-0039-0
Autor:
Allan Bundgaard, Jan Buch
Publikováno v:
Acta Pharmacologica et Toxicologica. 54:183-188
8 stable asthmatics were at random given placebo, 0.125 mg, 0.25 mg, 0.5 mg and 1 mg terbutaline intramuscularly or 2.5 mg as inhalation. Systolic time intervals, echocardiographic parameters and peak expiratory flow (PEF) were measured. Maximal circ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb529bc236b9cac08c7246bacedc398
https://doi.org/10.1111/j.1600-0773.1984.tb01915.x
https://doi.org/10.1111/j.1600-0773.1984.tb01915.x
Autor:
Annette Buch, Jan Buch
Publikováno v:
Acta Pharmacologica et Toxicologica. 53:188-192
Is is well known from laboratory investigations and acute intervention studies that glucagon is involved in lipid metabolism. The present study was undertaken in order to evaluate a possible sustained effect of zinc-protamin-glucagon in moderately hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b870ec09d22248f2609f7e02a70baae
https://doi.org/10.1111/j.1600-0773.1983.tb01123.x
https://doi.org/10.1111/j.1600-0773.1983.tb01123.x
Autor:
Mary Walter, Jan Buch, R. Preston Mason, Barrett W. Jeffers, Prevent Investigators, Yoshiko Mizuno, Robert F. Jacob, Rebekah E. Bjork
Publikováno v:
Journal of the American College of Cardiology. 51(12):1196-1202
Objectives This study was designed to determine the predictive value of lipid hydroperoxide (LOOH) levels for adverse cardiovascular outcomes in patients with stable coronary artery disease (CAD). Background Oxidative modification of circulating lipi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88469555ab6094282c3ec19bb5e0b60
Autor:
Mathieu Ghadanfar, Mary Walter, Jan Buch, Robert F. Jacob, Gregory M. Preston, R. Preston Mason, Barrett W. Jeffers
Publikováno v:
Journal of the American College of Cardiology. 44:1996-2002
Objectives The objective of this study was to test the predictive value of an oxidative stress biomarker in 634 patients from the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT). Background Oxidative stress contri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1750aba24fafd6d3c0a6b99960bcb02b
https://doi.org/10.1016/j.jacc.2004.08.029
https://doi.org/10.1016/j.jacc.2004.08.029
Autor:
Carla Yunis, John E. Deanfield, Jan Buch, Phillipe Sellier, Erik Thaulow, Jan Bultas, Harry Shi, Bruce Beckerman
Publikováno v:
European heart journal. 31(21)
Aims The DoUble-blind Atorvastatin AmLodipine (DUAAL) trial investigated whether atorvastatin decreases ischaemia by a vascular benefit, independent of low-density lipoprotein cholesterol lowering, in patients with coronary artery disease (CAD), both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b324f2fa5ba260b479164f8d67446e
https://pubmed.ncbi.nlm.nih.gov/20616096
https://pubmed.ncbi.nlm.nih.gov/20616096
Autor:
Mary F, Walter, Robert F, Jacob, Rebekah E, Bjork, Barrett, Jeffers, Jan, Buch, Yoshiko, Mizuno, R Preston, Mason
Publikováno v:
Journal of the American College of Cardiology. 51(12)
This study was designed to determine the predictive value of lipid hydroperoxide (LOOH) levels for adverse cardiovascular outcomes in patients with stable coronary artery disease (CAD).Oxidative modification of circulating lipids contributes to infla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6301a55bbb55afba6100b232ea37e6c3
https://pubmed.ncbi.nlm.nih.gov/18355658
https://pubmed.ncbi.nlm.nih.gov/18355658
Autor:
Mary F, Walter, Robert F, Jacob, Barrett, Jeffers, Mathieu M, Ghadanfar, Gregory M, Preston, Jan, Buch, R Preston, Mason
Publikováno v:
Journal of the American College of Cardiology. 44(10)
The objective of this study was to test the predictive value of an oxidative stress biomarker in 634 patients from the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT).Oxidative stress contributes to mechanisms of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::31abb34a3d100f654834bb7ce0a71d44
https://pubmed.ncbi.nlm.nih.gov/15542282
https://pubmed.ncbi.nlm.nih.gov/15542282